Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD (RAINBOW)
A Retrospective and Prospective Non-interventional Open Label Study to Assess the Real Life of Treatment-naive Patients With Wet Age-related Macular Degeneration in Routine Clinical Practice in France and Starting an Anti VEGF Therapy With Aflibercept
Sponsor: Bayer
Listed as NCT02279537, this observational or N/A phase trial focuses on Wet Macular Degeneration and remains completed. Sponsored by Bayer, it has been updated 24 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
24 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2023 [monthly]
Completed
-
May 2020 — Jan 2021 [monthly]
Completed
▶ Show 19 earlier versions
-
Aug 2019 — May 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Active Not Recruiting
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Active Not Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Active Not Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Active Not Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Apr 2017 — Jan 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
- Regeneron Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .